Investigation on the molecular mechanism of NPC1L1-mediated cholesterol uptake
NPC1L1介导胆固醇摄取的分子机制研究
基本信息
- 批准号:18390047
- 负责人:
- 金额:$ 6.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Cumulative evidence suggests that Niemann-Pick Cl-like 1 (NPClL1) is essential for intestinal cholesterol absorption and is the target of ezetimibe, a novel cholesterol-lowering drug. In this project, we isolated human NPClL1 cDNA and constructed human NPClL1-overexpressing Caco-2 cells. NPClL1 protein was mainly detected on the apical membrane, which reflects the physiological expression of NPClL1 on the intestinal brush border membrane. It was also shown that the transport activities of cholesterol were positively correlated with the expression level of introduced NPClL1 and ezetimibe inhibited the uptake in a concentration-dependent manner. In addition, since it has also been established that the transfer of cholesterol across the plasma membrane via many kinds of transporters and/or receptors is associated with the transfer of phospholipids, we examined whether the uptake of cholesterol by NPClL1 also takes place in the lipid-associated mechanism. It was found that overexpression of NPClL1 results in an increase in the uptake of both cholesterol and phosphatidylcholine from micelles composed of cholesterol, phosphatidylcholine and taurocholate but that the level of transport activity for cholesterol was much higher than that for phosphatidylcholine. In addition, the uptake of phosphatidylcholine was much less sensitive to ezetimibe than the uptake of cholesterol. In contrast, NPClL1-mediated uptake of taurocholate was minimal. It was also demonstrated that the uptake and ezetimibe-sensitivity of phosphatidylcholine and taurocholate from the micelles were not affected by the presence of cholesterol. Taken together, the results suggested that cholesterol is a preferable substrate of NPClL1 in micellar components and the inhibitory effect of ezetimibe is relatively selective to cholesterol uptake, although NPClL1 has potent activity for uptake of phospholipids from micelles.
累积证据表明,Niemann-Pick Cl-like 1 (NPClL1) 对于肠道胆固醇吸收至关重要,并且是新型降胆固醇药物依折麦布的靶标。在这个项目中,我们分离了人NPC1L1 cDNA并构建了人NPC1L1过表达的Caco-2细胞。 NPClL1蛋白主要在顶膜上检测到,这反映了NPClL1在肠刷状缘膜上的生理表达。还表明胆固醇的转运活性与引入的NPC1L1的表达水平呈正相关,并且依折麦布以浓度依赖性方式抑制摄取。此外,由于已经确定胆固醇通过多种转运蛋白和/或受体跨质膜的转移与磷脂的转移相关,因此我们检查了NPClL1对胆固醇的摄取是否也发生在脂质相关机制中。发现NPC1L1的过度表达导致从由胆固醇、磷脂酰胆碱和牛磺胆酸盐组成的胶束中对胆固醇和磷脂酰胆碱的摄取增加,但胆固醇的转运活性水平远高于磷脂酰胆碱的转运活性水平。此外,磷脂酰胆碱的摄取对依折麦布的敏感性远低于胆固醇的摄取。相反,NPC1L1介导的牛磺胆酸盐的摄取是最小的。还证明胶束中磷脂酰胆碱和牛磺胆酸盐的摄取和依折麦布敏感性不受胆固醇存在的影响。总而言之,结果表明胆固醇是胶束成分中NPC1L1的优选底物,并且依折麦布的抑制作用对胆固醇摄取具有相对选择性,尽管NPC1L1对于从胶束中摄取磷脂具有有效的活性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury.
吲哚美辛诱导的肠道损伤大鼠中 BSP 肝脏转运蛋白的下调。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Fujiyama N;Shitara Y;Ito K;Masubuchi Y;Horie T
- 通讯作者:Horie T
Oxidative stress and Mrp2 internalization.
- DOI:10.1016/j.freeradbiomed.2006.02.015
- 发表时间:2006-06
- 期刊:
- 影响因子:7.4
- 作者:Shuichi Sekine;Kousei Ito;T. Horie
- 通讯作者:Shuichi Sekine;Kousei Ito;T. Horie
Cholesterol lowering effect of ezetimibe in UDP-glucuronosyl transferase (UGT) 1A deficient (Gunn) rats
依折麦布对 UDP-葡萄糖醛酸转移酶 (UGT) 1A 缺陷 (Gunn) 大鼠的胆固醇降低作用
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Takehito Yamamoto;Kousei Ito;Masashi Honma;Tappei Takada;Hiroshi Suzuki
- 通讯作者:Hiroshi Suzuki
Cholesterol-lowering effect of ezetimibe in uridine diphosphate glucuronosyltransferase 1A-dedicient (Gunn) rats
依折麦布对尿苷二磷酸葡萄糖醛酸转移酶 1A 缺陷 (Gunn) 大鼠的降胆固醇作用
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yamamoto T;et. al.
- 通讯作者:et. al.
Cholesterol lowering effect of ezetimibe in UDP-glucuronosyl transferase (UGT) 1A deficient (Gunn) rats.
依折麦布对 UDP-葡萄糖醛酸转移酶 (UGT) 1A 缺陷 (Gunn) 大鼠的胆固醇降低作用。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:山本武人、その;他
- 通讯作者:他
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ITO Kousei其他文献
ITO Kousei的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ITO Kousei', 18)}}的其他基金
Construction of improved lymphocyte transformation test based on the onset and aggravation mechanism of drug-induced liver injury
基于药物性肝损伤发病及加重机制的改良淋巴细胞转化试验构建
- 批准号:
25670068 - 财政年份:2013
- 资助金额:
$ 6.98万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of the molecular mechanism of hepatic GSH decrease during drug induced liver injury.
药物性肝损伤过程中肝脏GSH降低的分子机制分析
- 批准号:
22790146 - 财政年份:2010
- 资助金额:
$ 6.98万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
相似海外基金
VTA dopamine connectivity and functional responses to drugs of abuse
VTA 多巴胺连接和对滥用药物的功能反应
- 批准号:
10665966 - 财政年份:2023
- 资助金额:
$ 6.98万 - 项目类别:
Epitranscriptomic Regulation of Synaptic Responses to Drugs of Abuse
对滥用药物的突触反应的表观转录调控
- 批准号:
10433956 - 财政年份:2018
- 资助金额:
$ 6.98万 - 项目类别:
Epitranscriptomic Regulation of Synaptic Responses to Drugs of Abuse
对滥用药物的突触反应的表观转录调控
- 批准号:
10194438 - 财政年份:2018
- 资助金额:
$ 6.98万 - 项目类别:
Immune responses to drugs that cause idiosyncratic liver injury and agranulocytosis
对引起特异质肝损伤和粒细胞缺乏症的药物的免疫反应
- 批准号:
320828 - 财政年份:2015
- 资助金额:
$ 6.98万 - 项目类别:
Operating Grants
Binging on palatable food and responses to drugs of abuse
暴饮暴食和对滥用药物的反应
- 批准号:
417284-2011 - 财政年份:2011
- 资助金额:
$ 6.98万 - 项目类别:
University Undergraduate Student Research Awards
Influence of inflammation on airway responses to drugs
炎症对气道药物反应的影响
- 批准号:
nhmrc : 920070 - 财政年份:1992
- 资助金额:
$ 6.98万 - 项目类别:
NHMRC Project Grants